What is Tivozanib: Uses, Dosage, Side Effects and More

Tivozanib is a targeted cancer medication that helps slow the growth of kidney cancer tumors. It belongs to a class of drugs called tyrosine kinase inhibitors, which work by blocking specific proteins that cancer cells need to grow and spread.

This medication represents an important treatment option for people with advanced kidney cancer, particularly when other treatments haven't worked as well as hoped. Understanding how tivozanib works and what to expect can help you feel more confident about your treatment journey.

What is Tivozanib?

Tivozanib is an oral cancer medication specifically designed to treat advanced renal cell carcinoma, the most common type of kidney cancer. The drug comes as capsules that you take by mouth, making it more convenient than treatments that require hospital visits.

This medication is what doctors call a "targeted therapy" because it focuses on specific pathways that cancer cells use to survive and multiply. Unlike chemotherapy, which affects many different types of cells, tivozanib is designed to be more precise in its action.

The drug received approval from the FDA in 2021, making it a relatively newer option in the kidney cancer treatment landscape. It's typically prescribed when other standard treatments have stopped working effectively.

What is Tivozanib Used For?

Tivozanib is primarily used to treat advanced renal cell carcinoma in adults who have already tried other kidney cancer treatments. Your doctor might recommend this medication when your cancer has spread to other parts of your body or when tumors have grown despite previous treatments.

The medication is specifically approved for patients who have received at least two prior systemic therapies. This means you've likely tried other targeted therapies or immunotherapy treatments before your doctor considers tivozanib as your next step.

In clinical studies, tivozanib has shown effectiveness in slowing tumor growth and helping people live longer without their cancer progressing. While it's not a cure, it can help control the disease and maintain quality of life for many patients.

How Does Tivozanib Work?

Tivozanib works by blocking specific proteins called VEGF receptors that cancer cells use to create new blood vessels. Think of it like cutting off the supply lines that tumors need to grow and thrive.

Cancer tumors are clever at creating their own blood supply through a process called angiogenesis. These new blood vessels bring oxygen and nutrients that help tumors grow larger and spread to other parts of the body.

By blocking these pathways, tivozanib essentially starves the tumor of what it needs to expand. This approach is considered a moderately strong treatment option, particularly effective for kidney cancer cells that depend heavily on these specific growth signals.

The medication also targets other related proteins involved in cancer cell survival, making it a multi-targeted approach that can be more effective than treatments that focus on just one pathway.

How Should I Take Tivozanib?

Tivozanib is taken as capsules by mouth, typically once daily for 21 days followed by a 7-day break. This pattern creates what doctors call a "cycle" of treatment, and you'll repeat this cycle as long as the medication continues to help control your cancer.

You can take tivozanib with or without food, but try to take it at the same time each day to maintain steady levels in your body. Swallow the capsules whole with a glass of water - don't crush, chew, or open them as this can affect how the medication works.

If you have trouble swallowing capsules, talk to your healthcare team about strategies that might help. Some people find it easier to take capsules with slightly thicker liquids or by using special techniques their pharmacist can teach them.

During your 7-day break periods, your body gets a chance to recover from any side effects while still maintaining the treatment's anti-cancer effects. This scheduled break is an important part of how tivozanib is designed to work.

How Long Should I Take Tivozanib For?

The length of tivozanib treatment varies significantly from person to person, depending on how well your cancer responds and how you tolerate the medication. Some people take it for several months, while others may continue for years.

Your doctor will monitor your progress regularly through scans and blood tests to see how well the treatment is working. As long as your cancer remains stable or shrinks, and you're managing the side effects well, you'll likely continue taking tivozanib.

Treatment typically continues until your cancer progresses despite the medication, or until side effects become too difficult to manage. Your healthcare team will work closely with you to determine the right duration for your specific situation.

The goal is to find the sweet spot where the medication effectively controls your cancer while maintaining your quality of life. Regular check-ups help ensure you're getting the maximum benefit from your treatment.

What Are the Side Effects of Tivozanib?

Like all cancer medications, tivozanib can cause side effects, though not everyone experiences them the same way. Most side effects are manageable, and your healthcare team has strategies to help you feel as comfortable as possible during treatment.

Understanding what to expect can help you recognize side effects early and get the support you need. Here are the most common side effects people experience:

• Fatigue and feeling more tired than usual
• Diarrhea or changes in bowel movements
• High blood pressure
• Decreased appetite
• Nausea or stomach upset
• Voice changes or hoarseness
• Weight loss
• Mouth sores or taste changes

These common side effects often improve as your body adjusts to the medication, and there are many effective ways to manage them with your healthcare team's guidance.

Some people may experience less common but more serious side effects that require immediate medical attention. While these are rarer, it's important to be aware of them:

• Signs of bleeding, such as unusual bruising or blood in urine or stool
• Severe high blood pressure with symptoms like severe headache or vision changes
• Signs of heart problems, including chest pain or shortness of breath
• Severe diarrhea that doesn't respond to treatment
• Signs of blood clots, such as sudden leg swelling or chest pain
• Severe skin reactions or rashes
• Signs of liver problems, including yellowing of skin or eyes

Your healthcare team will monitor you carefully for these more serious effects through regular check-ups and blood tests, catching any issues early when they're most treatable.

Who Should Not Take Tivozanib?

Certain health conditions and medications can make tivozanib unsuitable or require special precautions. Your doctor will carefully review your medical history to ensure this medication is safe for you.

You should not take tivozanib if you're allergic to the medication or any of its ingredients. People with severe liver problems may also need to avoid this treatment, as the liver processes the medication.

Several conditions require extra caution and close monitoring when taking tivozanib:

• History of heart problems or heart attacks
• High blood pressure that's difficult to control
• History of bleeding disorders or recent surgery
• Blood clotting disorders
• Liver disease or elevated liver enzymes
• Kidney problems beyond your cancer
• History of stroke or mini-strokes

Pregnancy and breastfeeding are also important considerations, as tivozanib can harm developing babies and may pass into breast milk.

Your doctor will weigh these factors carefully against the potential benefits of treatment, often finding ways to manage risks while still providing effective cancer care.

Tivozanib Brand Names

Tivozanib is available under the brand name Fotivda in the United States. This is the commercial name you'll see on your prescription bottle and medication packaging.

The medication is manufactured by AVEO Pharmaceuticals, and you might see their name on your prescription materials as well. Some insurance companies and pharmacies may refer to it by either the brand name Fotivda or the generic name tivozanib.

When discussing your medication with healthcare providers or pharmacists, using either name will help them understand exactly which treatment you're taking. The important thing is that the active ingredient remains the same regardless of which name is used.

Tivozanib Alternatives

Several other medications can treat advanced kidney cancer, each working through different mechanisms to control the disease. Your doctor might consider these alternatives if tivozanib isn't suitable for you or if your cancer progresses.

Other targeted therapies for kidney cancer include medications that work on similar pathways but may have different side effect profiles or effectiveness for your specific situation:

• Sunitinib (Sutent) - another VEGF receptor inhibitor
• Pazopanib (Votrient) - targets similar pathways with different side effects
• Axitinib (Inlyta) - often used after other treatments
• Cabozantinib (Cabometyx) - blocks multiple growth pathways
• Lenvatinib (Lenvima) - sometimes combined with other treatments

Immunotherapy options have also become important alternatives, helping your immune system recognize and attack cancer cells more effectively.

The choice between these alternatives depends on your specific cancer characteristics, previous treatments, overall health, and personal preferences. Your oncologist will help you understand which option might work best for your unique situation.

Is Tivozanib Better Than Sorafenib?

Clinical studies have shown that tivozanib may offer certain advantages over sorafenib, particularly in terms of progression-free survival and some side effects. However, "better" depends on your individual circumstances and treatment history.

In head-to-head comparisons, tivozanib demonstrated longer progression-free survival, meaning people's cancer stayed stable longer before progressing. Many patients also experienced fewer certain side effects, particularly the hand-foot syndrome that can be troublesome with sorafenib.

However, both medications have their place in kidney cancer treatment. Sorafenib has been available longer and has extensive real-world experience, while tivozanib offers a newer approach with potentially improved tolerability.

Your doctor will consider factors like your previous treatments, current health status, and specific cancer characteristics when determining which medication might work better for you personally.